Smith & Nephew (SNN) Income from Non-Controlling Interests (2009 - 2021)
Smith & Nephew (SNN) posted quarterly Income from Non-Controlling Interests of $20.0 million for Q4 2021, up 126.32% year-on-year from $8.8 million in Q4 2020, and up 126.32% on a QoQ basis from -$76.0 million in Q4 2020.
Smith & Nephew (SNN) Income from Non-Controlling Interests (2009 - 2021) Analysis & Trends
Smith & Nephew (SNN) has reported Income from Non-Controlling Interests for 6 consecutive years, with $20.0 million the latest figure, recorded in Q4 2021.
- Quarterly Income from Non-Controlling Interests rose 126.32% year-over-year to $20.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$154.0 million (down 50.98% YoY) and the FY2022 annual result came in at -$90.0 million, down 325.0% from the prior year.
- Income from Non-Controlling Interests advanced to $20.0 million in Q4 2021 per SNN's latest filing, from -$76.0 million in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for SNN reached as high as $20.0 million in Q4 2021 and fell as low as -$102.0 million in Q4 2018.
- A 4-year average of -$38.5 million and a median of -$36.0 million in 2019 frame the typical range for Income from Non-Controlling Interests.
- Annual changes were most pronounced in 2020 — Income from Non-Controlling Interests tumbled 2000.0% — and 2021, when it jumped 126.32%.
- Year by year, Income from Non-Controlling Interests stood at -$102.0 million in 2018, then surged by 103.92% to $4.0 million in 2019, then slumped by 2000.0% to -$76.0 million in 2020, then soared by 126.32% to $20.0 million in 2021.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $20.0 million, -$76.0 million, and $4.0 million for Q4 2021, Q4 2020, and Q4 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 20.00 Mn |
| Dec 31, 2020 | -76.00 Mn |
| Dec 31, 2019 | 4.00 Mn |
| Dec 31, 2018 | -102.00 Mn |
| Dec 31, 2010 | 72.00 Mn |
| Sep 30, 2010 | 77.00 |
| Jun 30, 2010 | -183.00 |
| Mar 31, 2010 | 77.00 |
| Dec 31, 2009 | 91.00 Mn |
| Sep 30, 2009 | 42.00 |
| Jun 30, 2009 | -18.00 |
| Mar 31, 2009 | 42.00 |